BioMarin reports early VOXZOGO treatment benefits for achondroplasia
Go back to BioMarin reports early VOXZOGO treatment benefits for achondroplasia| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 58.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.79 | 52 Week High | $108.96 | |||
| Open | $58.79 | 52 Week Low | $62.12 | |||
| Day High | $58.79 | P/E | N/A | |||
| Day Low | $58.79 | EPS | $-1.27 | |||
| Volume | 1,110 | |||||
